153 related articles for article (PubMed ID: 2832935)
1. Unprocessed bran and intermittent thiazide therapy in prevention of recurrent urinary calcium stones.
Ala-Opas M; Elomaa I; Porkka L; Alfthan O
Scand J Urol Nephrol; 1987; 21(4):311-4. PubMed ID: 2832935
[TBL] [Abstract][Full Text] [Related]
2. Rice bran treatment for patients with hypercalciuric stones: experimental and clinical studies.
Ohkawa T; Ebisuno S; Kitagawa M; Morimoto S; Miyazaki Y; Yasukawa S
J Urol; 1984 Dec; 132(6):1140-5. PubMed ID: 6094846
[TBL] [Abstract][Full Text] [Related]
3. [Prevention of urinary calculi with thiazides and allopurinol. A long-term study].
May P; Pilorz H; Duhme C; Pöpperl H; Braun J
Urologe A; 1984 Mar; 23(2):87-90. PubMed ID: 6426113
[TBL] [Abstract][Full Text] [Related]
4. Results of long-term rice bran treatment on stone recurrence in hypercalciuric patients.
Ebisuno S; Morimoto S; Yasukawa S; Ohkawa T
Br J Urol; 1991 Mar; 67(3):237-40. PubMed ID: 1902388
[TBL] [Abstract][Full Text] [Related]
5. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
6. Rice bran treatment for hypercalciuric patients with urinary calculous disease.
Ohkawa T; Ebisuno S; Kitagawa M; Morimoto S; Miyazaki Y
J Urol; 1983 May; 129(5):1009-11. PubMed ID: 6304355
[TBL] [Abstract][Full Text] [Related]
7. [Thiazide treatment for calcium urolithiasis in patients with idiopathic hypercalciuria].
Kurita Y; Kageyama S; Ishikawa A; Ushiyama T; Ohta N; Suzuki K; Kawabe K
Hinyokika Kiyo; 1994 Jun; 40(6):479-83. PubMed ID: 8073954
[TBL] [Abstract][Full Text] [Related]
8. Changes in urinary risk profile after short-term low sodium and low calcium diet in recurrent Swiss kidney stone formers.
Seeger H; Kaelin A; Ferraro PM; Weber D; Jaeger P; Ambuehl P; Robertson WG; Unwin R; Wagner CA; Mohebbi N
BMC Nephrol; 2017 Dec; 18(1):349. PubMed ID: 29202723
[TBL] [Abstract][Full Text] [Related]
9. Effect of unprocessed wheat bran on calciuria and oxaluria in patients with urolithiasis.
Gleeson MJ; Thompson AS; Mehta S; Griffith DP
Urology; 1990 Mar; 35(3):231-4. PubMed ID: 2156368
[TBL] [Abstract][Full Text] [Related]
10. Effect of thiazide on urinary calcium excretion and hematuria in children with postglomerular hematuria.
Reusz GS; Tulassay T; Szabò A; Miltényi M
Int J Pediatr Nephrol; 1987; 8(3):147-51. PubMed ID: 3429138
[TBL] [Abstract][Full Text] [Related]
11. Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines.
Skolarikos A; Straub M; Knoll T; Sarica K; Seitz C; Petřík A; Türk C
Eur Urol; 2015 Apr; 67(4):750-63. PubMed ID: 25454613
[TBL] [Abstract][Full Text] [Related]
12. Thiazide prophylaxis of urolithiasis. A double-blind study in general practice.
Laerum E; Larsen S
Acta Med Scand; 1984; 215(4):383-9. PubMed ID: 6375276
[TBL] [Abstract][Full Text] [Related]
13. Urinary oxalate in summer and winter in normal subjects and in stone-forming patients with idiopathic hypercalciuria, both untreated and treated with thiazide and/or cellulose phosphate.
Hallson PC; Kasidas GP; Rose GA
Urol Res; 1976; 4(4):169-73. PubMed ID: 1020068
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of hypercalciuria found in urolithiasis patients].
Yamaguchi K; Miyauchi T; Usui T; Murakami M; Ito H; Shimazaki J
Hinyokika Kiyo; 1985 Jan; 31(1):17-22. PubMed ID: 3993493
[TBL] [Abstract][Full Text] [Related]
15. Idiopathic hypercalciuria: its control with unprocessed bran.
Shah PJ; Williams G; Green NA
Br J Urol; 1980 Dec; 52(6):426-9. PubMed ID: 6257320
[TBL] [Abstract][Full Text] [Related]
16. Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions.
Pak CY; Heller HJ; Pearle MS; Odvina CV; Poindexter JR; Peterson RD
J Urol; 2003 Feb; 169(2):465-9. PubMed ID: 12544288
[TBL] [Abstract][Full Text] [Related]
17. Metabolic effects of thiazide versus placebo in patients under long-term treatment for recurrent urolithiasis.
Laerum E
Scand J Urol Nephrol; 1984; 18(2):143-9. PubMed ID: 6463598
[TBL] [Abstract][Full Text] [Related]
18. Seasonal variation of urinary calcium and oxalate excretion, serum 25(OH)D3 and albumin level in relation to renal stone formation.
Elomaa I; Karonen SL; Kairento AL; Pelkonen R
Scand J Urol Nephrol; 1982; 16(2):155-61. PubMed ID: 7123167
[TBL] [Abstract][Full Text] [Related]
19. Effect of hydrochlorothiazide therapy on the crystallization of calcium oxalate in urine.
Woelfel A; Kaplan RA; Pak CY
Metabolism; 1977 Feb; 26(2):201-5. PubMed ID: 834153
[TBL] [Abstract][Full Text] [Related]
20. The use of thiazides in the prevention of renal calculi.
Yendt ER; Guay GF; Garcia DA
Can Med Assoc J; 1970 Mar; 102(6):614-20. PubMed ID: 5437394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
